The Journal of pediatrics · 2004
Surfactant administration acutely affects cerebral and systemic hemodynamics and gas exchange in very-low-birth-weight infants.
Клиническое исследованиеСтатьяПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kaiser Jeffrey R, Gauss C Heath, Williams D Keith
Аннотация
OBJECTIVES: To determine whether surfactant administration affects cerebral and systemic hemodynamics and gas exchange in very low birth weight infants and to determine the predominant factor influencing changes in mean cerebral blood flow velocity (mCBFv) after surfactant instillation.
STUDY DESIGN: Fourteen very low birth weight infants with respiratory distress syndrome had continuous monitoring of mCBFv, Paco(2), mean arterial blood pressure (MABP), and Pao(2) before, during, and after the second dose of surfactant. Peak values and relative changes of the 4 variables for 45 minutes after surfactant were calculated. Logistic regression was used to determine the predominant factor influencing changes in mCBFv after surfactant.
RESULTS: Birth weight was 832 +/- 162 grams and gestational age was 25.7 +/- 1.5 weeks. The time from birth to monitoring was 6.9 +/- 1.0 hours. Mean CBFv increased 75.7% +/- 51.6% after surfactant and peaked at 14.4 +/- 5.9 minutes. Paco(2) was highly associated (OR=107.3, P <.0001) with mCBFv; as Paco(2) increased, mCBFv increased. In contrast, MABP (OR=6.7, P=.047) had less impact on mCBFv. Pao(2) was not associated with mCBFv.
CONCLUSIONS: The increases in mCBFv after surfactant administration were predominantly due to increases in Paco(2) and not changes in MABP.
STUDY DESIGN: Fourteen very low birth weight infants with respiratory distress syndrome had continuous monitoring of mCBFv, Paco(2), mean arterial blood pressure (MABP), and Pao(2) before, during, and after the second dose of surfactant. Peak values and relative changes of the 4 variables for 45 minutes after surfactant were calculated. Logistic regression was used to determine the predominant factor influencing changes in mCBFv after surfactant.
RESULTS: Birth weight was 832 +/- 162 grams and gestational age was 25.7 +/- 1.5 weeks. The time from birth to monitoring was 6.9 +/- 1.0 hours. Mean CBFv increased 75.7% +/- 51.6% after surfactant and peaked at 14.4 +/- 5.9 minutes. Paco(2) was highly associated (OR=107.3, P <.0001) with mCBFv; as Paco(2) increased, mCBFv increased. In contrast, MABP (OR=6.7, P=.047) had less impact on mCBFv. Pao(2) was not associated with mCBFv.
CONCLUSIONS: The increases in mCBFv after surfactant administration were predominantly due to increases in Paco(2) and not changes in MABP.